This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
<MedicationRequest xmlns="http://hl7.org/fhir">
<id value="medicationrequest-for-bresentrik"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="medicationrequest-for-bresentrik"> </a><a name="hcmedicationrequest-for-bresentrik"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest "medicationrequest-for-bresentrik" </p></div><p><b>identifier</b>: <code>http://www.bmc.nl/portal/medstatements</code>/1234568900-studyDrug (use: official)</p><p><b>status</b>: active</p><p><b>intent</b>: order</p><h3>Medications</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Reference</b></td></tr><tr><td style="display: none">*</td><td><a href="Medication-bresentrik.html">Medication/bresentrik: bresentrik 2mg tablet</a></td></tr></table><p><b>subject</b>: <a href="Patient-JanetPatient.html">Patient/JanetPatient: Janet</a> " CLINICAL TRIAL PATIENT"</p><p><b>supportingInformation</b>: <a href="ResearchStudy-BreastCancerTrial.html">ResearchStudy/BreastCancerTrial: http://baseUrlOfHospitalHolding/PlanDefinition/protocol-for-the-ResearchStudy</a></p><p><b>authoredOn</b>: 2023-04-05</p><p><b>requester</b>: <span>: Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD</span></p><h3>Reasons</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Breast Cancer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#254837009)</span></td></tr></table><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 1</p><p><b>text</b>: 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL</p><p><b>timing</b>: Once per 1 days</p><p><b>route</b>: Oral route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote><blockquote><p><b>dispenseRequest</b></p><p><b>numberOfRepeatsAllowed</b>: 1</p><p><b>quantity</b>: 600 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><h3>ExpectedSupplyDurations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Value</b></td><td><b>Unit</b></td><td><b>System</b></td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td>30</td><td>days</td><td><a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-ucum.html">Unified Code for Units of Measure (UCUM)</a></td><td>d</td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="http://www.bmc.nl/portal/medstatements"/>
<value value="1234568900-studyDrug"/>
</identifier>
<status value="active"/>
<intent value="order"/>
<medication>
<reference>🔗
<reference value="Medication/bresentrik"/>
<display value="bresentrik 2mg tablet"/>
</reference>
</medication>
<subject>🔗
<reference value="Patient/JanetPatient"/>
<display value="Janet"/>
</subject>
<supportingInformation>🔗
<reference value="ResearchStudy/BreastCancerTrial"/>
<display
value="http://baseUrlOfHospitalHolding/PlanDefinition/protocol-for-the-ResearchStudy"/>
</supportingInformation>
<authoredOn value="2023-04-05"/>
<requester>
<display
value="Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD"/>
</requester>
<reason>
<concept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="254837009"/>
<display value="Breast Cancer"/>
</coding>
</concept>
</reason>
<dosageInstruction>
<sequence value="1"/>
<text
value="6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL"/>
<timing>
<repeat>
<frequency value="1"/>
<period value="1"/>
<periodUnit value="d"/>
</repeat>
</timing>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="26643006"/>
<display value="Oral route (qualifier value)"/>
</coding>
</route>
<doseAndRate>
<type>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/>
<code value="ordered"/>
<display value="Ordered"/>
</coding>
</type>
<doseQuantity>
<value value="6"/>
<unit value="mg"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</doseQuantity>
</doseAndRate>
</dosageInstruction>
<dispenseRequest>
<numberOfRepeatsAllowed value="1"/>
<quantity>
<value value="600"/>
<unit value="mg"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</quantity>
<expectedSupplyDuration>
<value value="30"/>
<unit value="days"/>
<system value="http://unitsofmeasure.org"/>
<code value="d"/>
</expectedSupplyDuration>
</dispenseRequest>
</MedicationRequest>